Melinta Therapeutics
Melinta Therapeutics's email is info@melinta.com
and
Melinta Therapeutics's phone number is (203) 624-5606
.
Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structur...
read more
Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.
show less
Website | melinta.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 170 | |
Founded | 2000 |
HQ | 300 George Street Suite 301 | |
Phone | (203) 624-5606 | |
info@melinta.com | ||
Funding | 877,400,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | melinta.com | |
Industry | Biotechnology | |
Location | United States | |
Employees | 170 | |
Founded | 2000 | |
linkedin.com/company/melinta-therapeutics | ||
HQ | 300 George Street Suite 301 | |
Phone | (203) 624-5606 | |
info@melinta.com | ||
Funding | 877,400,000 USD |
Email Patterns for Melinta Therapeutics
Top Competitors for Melinta Therapeutics
Melinta Therapeutics Questions
Where are Melinta Therapeutics's headquarters?
Melinta Therapeutics's headquarters are in 300 George Street Suite 301
What is Melinta Therapeutics's phone number?
Melinta Therapeutics's phone number is (203) 624-5606
What is Melinta Therapeutics's official website?
Melinta Therapeutics's website is melinta.com
How many employees are working in Melinta Therapeutics right now?
Melinta Therapeutics has
170 employees.
View the Email and Phone Numbers for all 170 working at Melinta Therapeutics.
What is Melinta Therapeutics's industry?
Melinta Therapeutics's industry is
Biotechnology
Who are Melinta Therapeutics's top competitors?
Melinta Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Melinta Therapeutics's email address?
Melinta Therapeutics's email address is info@melinta.com
What are Melinta Therapeutics's categories?
Melinta Therapeutics's categories are Biotechnology, Emergency Medicine, Health Care, Pharmaceutical
What is Melinta Therapeutics's location?
Melinta Therapeutics's location is
United States
When was Melinta Therapeutics's founded?
Melinta Therapeutics's founding year is 2000
What is Melinta Therapeutics's funding?
Melinta Therapeutics's funding is 877,400,000 USD
What is Melinta Therapeutics's current status?
Melinta Therapeutics's current status is acquired
Top Melinta Therapeutics Employees
National Account Director, Market Access
suttoneager@aol.com
+1717-258-9817
Director Of Market Access And Health Policy
ralph.ackerman@cubist.com
+1973-656-1616
Senior Accountant
mritab1@gmail.com
+1847-414-8727
Director, Product Quality Assurance And Compliance
stephen.weis@hospira.com
+1262-577-6367
Senior Director Regulatory Affairs
starr.shangle@themedco.com
+1973-290-6122
Medical Science Director
borgsj@shands.ufl.edu
+1386-292-8000
Key Account Manager
mmccloud@midwestmedical.net
+1412-889-2106